Our Team

For over 30 years Marcus & Associates has been entrusted as a search partner for a select group of clients who share our belief that our organizations’ most important resource is its people. We have strategically built our firm to mirror the organizational structure of our Life Sciences clients. We have functional area expertise in each of our Practice Areas. We are highly skilled in identifying, recruiting and closing seasoned industry leaders and fast-track rising stars, within their specialties from Early Research to Commercialization. We are consistently relied upon to fill key positions with the narrowest requirements.

About Our Practice Areas

The strength of our team is enhanced by the expertise our consultants have within their respective scientific, clinical, technical and commercial functions, derived from direct experience and sole focus working in their respective areas. Our decades of experience provides us with a unique insight into our industry and allow us to provide the highest level of service. We leverage our 400,000+ proprietary database as well as a multitude of other resources to generate leads to all of the qualified candidates available. The following is a more specific breakdown of the scientific, clinical, technical and commercial areas of the healthcare and Life Sciences industry that our teams service.

Meet Our
Management Team

President

Joshua Marcus

As President, Joshua Marcus has guided the business for over a decade through the pitfalls and joys of growth and change. He is adamant about keeping the firm boutique in size to ensure our ability to provide exceptional, targeted service. Josh is passionate about the industry and helping our clients find the best talent to ensure their success.

Senior Vice President

Rory Faulkner

Rory Faulkner has helped guide the business over the past 12 years and brings a diverse background to the team and skillset to each client project he manages. He earned a master’s degree in managerial communication from Arizona State University in Tempe, Arizona, and bachelors degree in business from the same school.

Senior Vice President

Ray Rodriguez

With over 14 years of providing leadership, Ray Rodriguez brings a strong management background to the team. As a former trainer for Dale Carnegie, Ray’s award winning managements skills have translated to exceptional service for our clients. Ray’s knowledge and passion about Life Sciences is evident in everything he does.

Meet Our
Advisors

Owner, Principal of Cosma Biopharma Consulting

Greg Cosma, Ph.D.

Bringing over 20 years of experience as a senior leader in the pharmaceutical industry, most recently as Vice President of Genentech Research and Early Development, Greg is currently Owner and Principal of Cosma Biopharma Consulting, LLC. Greg is currently a member of the Scientific Advisory Board of Immune-Onc Therapeutics and the R&D Advisory Board of Erasca, Inc. Greg has led efforts across R&D that have resulted in numerous approvals of currently marketed drugs, spanning diverse therapeutic areas and modalities. In addition to his broad development responsibilities at Genentech, Greg led Project Agility, an organization-wide effort to enhance innovation and pipeline delivery. He is widely considered as a trusted and transformative thought leader in the industry, applying disruptive strategies to enhance and accelerate pipeline delivery and efficiency. Prior to his career in biopharma, Greg was a faculty member at New York University Medical Center and Colorado State University.

Co-founder and President of Saccharo

Sheryl Martin-Moe, PhD

Sherry is a Biopharmaceutical executive leader with over 30 years experience in pharmaceutical, biotechnology, diagnostic and device industries in the US, Europe and ROW. She is a Concept to Product CMC expert with demonstrated success in bringing over 100 products through development, clinical trials and to market and supporting licensed products. She has a breadth of cross functional leadership experience, directing departments including: Analytical, Formulation, Device, and Processing Development; Clinical and Commercial Quality Control; and Clinical Production for Drug Substance and Drug Product. Sherry has established a scientific track record for designing and successfully implementing integrated programs including: CMC, Development, Operations, Combination Products, Technology Transfers, Drug Product Network Process, Comparability, QbD, Process Validation.

Co-founder and President of Intellectus Partners

Jay Casey

Within Intellectus, he specializes in advising and managing relationships with life sciences and tech clients. He is also responsible for day-to-day oversight of key operating units, including Investment Planning & Analytics, Strategic Product Management, and Risk & Quantitative Analysis. Prior to founding Intellectus Partners, Jay served as a Director at Deutsche Bank, where he was an Advisor and Portfolio Manager for more than a decade. He had oversight of the team’s investment strategies, including its fixed income, equity, liquidity, and alternative investment offerings. Jay earned his MBA in Finance and Entrepreneurship from Duke University’s Fuqua School of Business and his undergraduate degree from Appalachian State University. He also studied International Finance at Sasin of Chulalongkorn University in Thailand. Jay has earned a number of national accolades. On Wall Street recognized him as one of the Top 40 Advisors Under 40 in 2009 and Barron’s has named him one of the Top Advisors in America in multiple years.

Research & PreClinical Practice

Our Research & Preclinical Practice is unparalleled in identifying and recruiting functional experts and the industry’s leading drivers of science and technology across the wide breadth of scientific and technical specialties.